Skip to main content
Fig. 8 | Cardiovascular Diabetology

Fig. 8

From: Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Fig. 8

Relative expression (2−ΔCq × 103, ΔCq = Cq has-miRNA—Cq cel-miR-39) of miRNAs in plasma from patients with dyslipidemia (n = 14), diabetes (n = 17), diabetes associated with dyslipidemia (n = 17) and control subjects (n = 15): A miR-122-5p; B miR-155-5p; C miR 200-3p; D miR-218-5p; E miR-212-5p; F miR-126-3p. Data are expressed as means ± SD. &p < 0.05 (vs C), *p < 0.05 (vs DLP), # p < 0.05 (vs T2D) (One-Way ANOVA with Bonferroni's Multiple Comparison Test)

Back to article page